Contact Persons in Project 11: Supportive Care

Created by: Hellenbrecht (ELIC) , generated 2006/03/14, last changed: 2008/06/04

Name	Initials	Clinic	Country
Lead Participants
C. Fonatsch *	FON	Medizinische Universität	Austria
C. Haferlach *	HAF	Münchner Leukämie Labor (MLL)	Germany
H. Rieder	RIE	Universitätsklinikum Düsseldorf, Institut für Humangenetik und Anthropologie	Germany
Participants
M. Andersen *	AND	HS Rigshospitalet	Denmark
A. Aventin *	AVE	Institut de Recerca de l´Hospital de la Santa Creu i Sant Paul	Spain
P. Bernasconi	BERA		Italy
B. Beverloo *	BEV	Erasmus University Medical Center	Netherlands
N. Dastugue *	DAS	Centre Hospitalier Universitaire de Toulouse, Hotel-Dieu Saint Jaques	France
D. Grimwade	GRI	King´s College	UK
O. Haas	HAA	Children´s Cancer Research Institute	Austria
D. Haase	HAA	Georg-August-Universität	Germany
A. Hagemeijer *	HAG	Katholieke Universiteit	Belgium
J. Harbott	HARB	Justus-Liebig-Universität	Germany
J.M. Hernandez	HER		Spain
J.L. Huret	HUR	Université de Poitiers	France
B. Johansson	JOH	Lunds Universitet	Sweden
M. Jotterand *	JOT	Université de Lausanne	Switzerland
S. Knuutila	KNU	University of Helsinki	Finland
D. Lillington *	LIL	Queen Mary University of London	UK
T. Lion	LIO		Austria
C. Mecucci *	MEC	Università degli Studi di Perugia	Italy
F. Mitelman	MIT	Lunds Universitet	Sweden
J. Mufti	MUF		UK
M. Ogur *	OGU		Turkey
J. Pedersen-Bjergaard	PED	HS Rigshospitalet	Denmark
M. Rocchi	ROC	Università degli Studi di Bari	Italy
S. Romana	ROM	Institut National de la Santé et de la Recherche Médicale	France
C. Sambani *	SAM		Greece
B. Schlegelberger *	SCHL	Medizinische Hochschule Hannover	Germany
S. Stilgenbauer	STI	Universität Ulm	Germany
C.T. Storlazzi *	STOR		Italy
A. Tukun	TUK		Turkey
* = Female Researcher

Lead Participants:

Prof.Dr. C. Fonatsch (Wien, Austria): Longstanding experience in classical and molecular cytogenetics of leukemias and lymphomas with special interest in secondary AML. Responsible for cytogenetic diagnoses of leukemia patients of the University Hospital in Vienna (AKH) and other hospitals in Austria.

PD Dr. C. Haferlach (Munich, Germany): Experience in cytogenetics and FISH including 24-color-FISH and CGH. Responsible for a central reference laboratory that serves the AMLCG studies and the CML study (Mannheim) for cytogenetic diagnosis.

Prof.Dr. H. Rieder (Düsseldorf, Germany): Head of the tumor cytogenetics laboratory of the institute for human genetics Heinrich-Heine-Universität Düsseldorf; experience in tumor cytogenetics, including molecular cytogenetics (FISH, CGH, mFISH); responsible for the central cytogenetics within the German Multicenter Study Group for Adult ALL (GMALL). Scientist-in-charge of the Central Cytogenetics within the German Competence Network "Acute and chronic leukemias" and of the Coordination of quality control in leukemia cytogenetics of the Medical Geneticists Professionals Association, Germany.

Participants:

Dr. M. Andersen (Copenhagen, Denmark): Clinician at the Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. Experience in classical and molecular cytogenetics of leukemias.

Dr. A. Aventin (Barcelona, Spain): Scientific Topics: Elucidation of molecular gentetics in leucemias including apoptosis and gene rearrangements.

P. Bernasconi (, Italy):

Dr. B. Beverloo (Rotterdam, Netherlands): Clinical Cytogeneticist, Head of Tumorcytogenetic Laboratory, Dept of Clinical Genetics, Erasmus MC, Experience in classical and molecular cytogenetics of leukemias and lymphomas, (FISH, CGH and Spectral Karyotyping, array CGH is implemented); Responsible for (molecular) cytogenetic diagnoses of patients with hematological malignancies in the Southwest part of the Netherlands. Main focus of research is on the detection and identification of new (cryptic) chromosomal abnormalities in human hematological malignancies and their clinical relevance for prognosis and disease treatment. In addition the laboratory participates in the research program of the Institute of Genetics on genetic instability, by studying cytogenetic endpoints of genomic instability in DNA repair deficient mice and humans. Active member of Netherlands Workgroup for Cancer Genetics and Cytogenetics, of Cytogenetics and Molecular Genetics Committee of EORTC Leukemia Group.

Dr. N. Dastugue (Toulouse, France): Cytogenetic department, Centre Hospitalier Universitaire of Toulouse, France. Experience in cytogenetics and FISH. Reviewer of cytogenetic data of childhood ALL for the EORTC-CLCG group. Member of the board in the Groupe Français de Cytogénétique Hématologique (GFCH).

Dr. D. Grimwade (London, UK):

Prof.Dr. O. Haas (Vienna, Austria): Professor of laboratory medicine and associate Professor of human genetics. Head of the laboratory in the St. Anna Children's Hospital and Head of a research lab in the Children's Cancer Research Institute (CCRI), Vienna. He is a founding member and member of the board of the "European Cytogeneticists Association (ECA). In the International BFM ALL childhood study group he chairs the "Committee of Biology and Diagnosis" and is an advisor to the board.

D. Haase (Göttingen, Germany):

Prof.Dr. A. Hagemeijer (Leuven, Belgium): Catholic University of Leuven, Belgium. Head of Tumor Cytogenetics & Molecular Genetics Laboratory, Leuwen, Belgium. Chairman of the Cytogenetics & Molecular Genetics Committee of EORTC Leukemia Group. Member of Bureau and active member of the GFCH (Groupe Français de Cytogénétique Hématologique). Founding and active member of the NWCGC (Netherlands Workgroup for Cancer Genetics & Cytogenetics). Responsibe for translational and fundamental research programme into the role of gene alteration in leukemia.

Prof.Dr. J. Harbott (Gießen, Germany): Associated Professor of tumor genetics in the Department of Hematology and Oncology in Gießen. Leader of the central laboratory for cytogenetic and molecular genetic diagnostics of the German pediatric therapy trials ALL-BFM, CoALL, AML-BFM, NHL-BFM and of the research group Genetic Diagnostics in Leukemia. Member of several international co-operations.

J.M. Hernandez (, Spain):

Dr. J.L. Huret (Poitiers, France): Editor of the Atlas of Genetics and Cytogenetics in Oncology and Hematology. Experience in cytogenetics of leukemias/lymphomas. Experience in internet and databases. Active member of the Groupe Français de Cytogénétique Hématologique.

Prof.Dr. B. Johansson (Lund, Sweden): Professor at the Department of Clinical Genetics, University of Lund, Sweden. Associate Editor of Genes, Chromosomes & Cancer; Associate Editor of Database of Chromosome Aberrations in Cancer. Member of the Nordic childhood leukemia cytogenetics group, Member of the permanent working group "Cytogenetics of haematological malignancies", European Cytogenetics Association.

Prof.Dr. M. Jotterand (Lausanne, Switzerland): Head of the Unité de cytogénétique du cancer, Service de génétique médicale, Centre hospitalier universitaire vaudois (CHUV). Longstanding experience in cytogenetics, particularly in malignant hemopathies. Responsible of the Swiss referring laboratory for the Leukemia group of the Swiss group for clinical cancer research and for the cytogenetic diagnosis of leukemia patients from all parts of Switzerland. The laboratory is accredited according to the ISO/IEC 17025 norm. Co-President of the Swiss Society of Medical Genetics and member of the Swiss Ethics Committee on Non-human Gene Technology (EKAH).

Prof.Dr. S. Knuutila (Helsinki, Finland): Director of the Laboratory of Cytomolecular Genetics, Haartman Institute and Helsinki University Central Hospital, University of Helsinki. Profound experience in cancer cytogenetics. Founder of one of the leading laboratories in the field of cytogenetic and molecular genetic routine diagnostics and research of hematologic malignancies and sarcomas. State-of-the-art methods and techniques, such as in situ hybridizations (FISH, M-FISH, CISH), combined immunophenotyping and genotyping (the MAC methodology), comparative genomic hybridization (CGH), cDNA and tissue arrays, and other molecular genetic techniques are well-established and used routinely in diagnostic and research work.

Dr. D. Lillington (London, UK): Head of Cytogenetics and Honoarary Lecturer, Cancer Research UK, St Bartholomew?s Hospital, London and on behalf of the United Kingdom Cancer Cytogenetics Group (UKCCG), Experience of cytogenetics and molecular cytogenetics (FISH, M-FISH, PETS, CGH and array-CGH) of hematological malignancies and solid tumours. Actively involved in clinical diagnostic cytogenetics and research, including the use of 1Mb CGH arrays (from the Sanger Centre) for the investigation of AML and retinoblastoma. Special interests include de novo and secondary AML and retinoblastoma. Member of the UKCCG steering committee and was involved in the European workshop on 11q23 abnormalities (organised by Prof Lorna Secker-Walker) and the International workshop on therapy related leukemias (organised by Prof. Janet Rowley).

T. Lion (, Austria):

Prof.Dr. C. Mecucci (Perugia, Italy): Associate Professor of Hematology and Head of the Laboratory of Cytogenetics of the Hematology Unit of the University of Perugia. Scientific topics: cancer cytogenetics (both conventional and molecular cytogenetics), for diagnostic purposes and research projects. Consultant for the GIMEMA Italian Group for treatment of acute leukemias in adults. Associate Editor of "Haematologica/The Hematology Journal". Member of the Editorial Board of: Cancer Genetics and Cytogenetics; Leukemia Research; Annales de Genetique.

Prof.Dr. F. Mitelman (Lund, Sweden): Chairman of the Department of Clinical Genetics, University of Lund, Sweden. One of the organizers of the International Workshops on Chromosomes in Leukemia. Has served as the chairman of the International Standing Committee on Human Cytogenetic Nomenclature and is the Editor of ISCN (1995), the presently used nomenclature system in human cytogenetics. Founder and curator of the Mitelman Database on Chromosome Aberrations in Cancer, an integrated component of the international interdisciplinary "Cancer Genome Anatomy Project".

Prof.Dr. J. Mufti (London, UK):

M. Ogur (, Turkey):

Prof.Dr. J. Pedersen-Bjergaard (Copenhagen, Denmark): Associate Head of the Cytogenetic Laboratory of the Department of Clinical Genetics, University of Copenhagen, Denmark. Scientific Topics: Elucidation of karyotype abnormalities of secondary acute nonlymphocytic leukemia due to therapy with different agents.

Dr. M. Rocchi (Bari, Italy): Professor of Cytogenetics, DAPEG, Sezione di Genetica, University of Bari, Main scientific interests: somatic cell genetics; gene mapping; the generation and characterization of resources for molecular cytogenetics of leukemias, genome plasticity in tumors. Dr. P. Romana (Paris, France): MCU-PH. Head of molecular cytogenetic unit (Necker hospital, Paris and INSERM EMI 0210, Paris). Research field in cytogenetics and molecular characterization of chromosomal rearrangements in hematological malignancies.

S. Romana (Paris, France):

C. Sambani (, Greece):

Prof.Dr. B. Schlegelberger (Hannover, Germany): Professor of Human Genetics and Head of the Institute of Cell and Molecular Pathology of Hannover Medical School. Scientific topics: chromosomal instability in leukemia and solid tumors, cytogenetic markers indicative of therapy response, genomic and epigenetic alterations during tumorigenesis. Refererence Specialist for EWOG-MDS98, AML-BFM-2000, AML-BFM, AML-SHG, MDS and CML4 multicenter clinical trials. Member of the Steering Committee of the Excellence Cluster "Rebirth" of the BMBF.

PD Dr. S. Stilgenbauer (Ulm, Germany): Department of Internal Medicine III, University of Ulm, Germany. Longstanding expertise in the field of genetic abnormalities in hematopoietic tumours including innovative technical approaches for the detection of genetic aberrations, identification and characterisation of novel aberrations and correlation of genetic aberrations with clinical parameters searching for novel prognostic factors and biologically tailored treatment. Coordinator of the central reference laboratory of the German CLL Study Group (GCLLSG).

C.T. Storlazzi (, Italy):

A. Tukun (, Turkey):